Will bargain-basement telehealth visits help pharma drive drug scripts?

As links between pharma and telehealth grow, experts sound alarms. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

April 23, 2026 Check out STAT+

Sponsored By

Good afternoon. Don't miss a limited-time deal that gets you 60% off your first year of STAT+. Get unlimited access to our biopharma and public health policy coverage, exclusive newsletters, special access to our events, and more. Discount offer is here, and thanks for reading!

Thumỹ Phan for STAT STAT+ | Will bargain-basement telehealth visits help pharma drive drug scripts? Cheap telehealth visits advertised by pharma could steer patients toward expensive branded drugs, raising concerns about potential anti-kickback violations. By Katie Palmer STAT+ | Publicly, Kennedy embraces a more moderate MAHA Across seven congressional hearings, RFK Jr. lightened his messaging on vaccines and pesticides, but the MAHA impact on policy continues to be felt. By Daniel Payne and Chelsea Cirruzzo STAT+ | Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling marijuana. By Lev Facher Library of Congress Opinion: Dropping the flu vaccine requirement puts U.S. military readiness at risk Retired general — also a doctor — says the secretary of defense erred in dropping annual flu shot requirement: "Asserting that flu poses no risk is untrue." By Paul Friedrichs STAT+ | Can Erasca be biotech’s next big thing? We’ll see In this week's edition of "Adam's Biotech Scorecard," Adam looks at a company seeking to outdo Revolution Medicines in cancer. By Adam Feuerstein Opinion: Kennedy’s new silence on vaccines is political — and it won’t last Kennedy’s lull in anti-vaccine rhetoric and action should not be mistaken for a durable pivot in federal vaccine policy. By Will Walters and Richard Hughes IV Adobe Heart’s beat may help it beat cancer, mouse research suggests Researchers say constant pressure from heart beat creates environment hostile to cancer. Findings could inspire massage-type treatments. By Anil Oza STAT+ | Legislatures in Colorado and Virginia resist moves to constrain drug affordability boards Attempts to constrain the boards come amid ongoing debate over the cost of prescription drugs and how to address the problem. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser